Silicon Labs Reports Fourth Quarter and Full Year 2025 Results

AUSTIN, Texas, Feb. 4, 2026 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported financial results for the fourth quarter and full year 2025, which ended January 3, 2026.

"The Silicon Labs team completed fiscal 2025 with continued strong execution, delivering an impressive year-over-year revenue growth of 34%," said Matt Johnson, President and Chief Executive Officer of Silicon Labs. "That momentum continues as we enter 2026 with record opportunity funnel and design win traction."

Due to the separately announced pending acquisition of Silicon Labs by Texas Instruments, Silicon Labs will cancel its previously announced earnings call scheduled for February 10, 2026, and has suspended providing forward-looking guidance.

Full Year 2025 Financial Highlights

Results on a GAAP basis:

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

Fourth Quarter Financial Highlights

Results on a GAAP basis:

About Silicon Labs

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.

Forward-Looking Statements

This press release contains forward-looking statements based on Silicon Labs' current expectations. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the impact of the current global memory chip shortage; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs' distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs' products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

Three Months Ended

Year Ended

January 3,

2026

December 28,

2024

January 3,

2026

December 28,

2024

Revenues

$ 208,206

$ 166,249

$ 784,764

$ 584,386

Cost of revenues

76,128

76,026

327,781

272,198

Gross profit

132,078

90,223

456,983

312,188

Operating expenses:

Research and development

89,521

82,438

353,246

332,225

Selling, general and administrative

45,809

36,412

174,278

145,453

Operating expenses

135,330

118,850

527,524

477,678

Operating loss

(3,252)

(28,627)

(70,541)

(165,490)

Other income (expense):

Interest income and other, net

2,932

2,978

13,604

11,987

Interest expense

(214)

(260)

(975)

(1,310)

Loss before income taxes

(534)

(25,909)

(57,912)

(154,813)

Provision (benefit) for income taxes

2,150

(2,086)

6,995

36,197

Net loss

$ (2,684)

$ (23,823)

$ (64,907)

$ (191,010)

Loss per share:

Basic

$ (0.08)

$ (0.73)

$ (1.98)

$ (5.93)

Diluted

$ (0.08)

$ (0.73)

$ (1.98)

$ (5.93)

Weighted-average common shares outstanding:

Basic

32,920

32,420

32,721

32,191

Diluted

32,920

32,420

32,721

32,191

Non-GAAP Financial Measurements

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

Three Months Ended

January 3, 2026

Non-GAAP Income Statement Items

GAAP

Measure

GAAP

Percent of

Revenue

Stock

Compensation

Expense

Intangible

Asset

Amortization

Other Costs

Non-GAAP

Measure

Non-GAAP

Percent of

Revenue

Revenues

$ 208,206

Gross profit

132,078

63.4 %

$ 400

$ —

$ 132,478

63.6 %

Research and development

89,521

43.0 %

12,190

2,295

404

74,632

35.8 %

Selling, general and administrative

45,809

22.0 %

8,089

—

461

37,259

17.9 %

Operating expenses

135,330

65.0 %

20,279

2,295

865

111,891

53.7 %

Operating income (loss)

(3,252)

(1.6 %)

20,679

2,295

865

20,587

9.9 %

Three Months Ended

January 3, 2026

Non-GAAP Earnings (Loss) Per Share

GAAP

Measure

Stock

Compensation

Expense*

Intangible

Asset

Amortization*

Other

Costs*

Income

Tax

Adjustments

Non-

GAAP

Measure

Net income (loss)

$ (2,684)

$ 20,679

$ 2,295

$ 865

$ (2,511)

$ 18,644

Shares Excluded Due to Net Loss

Diluted shares outstanding

32,920

279

33,199

Diluted earnings (loss) per share

$ (0.08)

$ 0.56

* Represents pre-tax amounts

Twelve Months Ended

January 3, 2026

Non-GAAP Income Statement Items

GAAP

Measure

GAAP

Percent of

Revenue

Stock

Compensation

Expense

Intangible

Asset

Amortization

Other Costs

Non-GAAP

Measure

Non-GAAP

Percent of

Revenue

Revenues

$ 784,764

Gross profit

456,983

58.2 %

$ 1,944

$ —

$ 458,927

58.5 %

Research and development

353,246

45.0 %

48,447

13,369

934

290,496

37.0 %

Selling, general and administrative

174,278

22.2 %

29,933

—

1,216

143,129

18.2 %

Operating expenses

527,524

67.2 %

78,380

13,369

2,150

433,625

55.3 %

Operating income (loss)

(70,541)

(9.0 %)

80,324

13,369

2,150

25,302

3.2 %

Twelve Months Ended

January 3, 2026

Non-GAAP Earnings (Loss) Per Share

GAAP

Measure

Stock

Compensation

Expense*

Intangible

Asset

Amortization*

Other

Costs*

Income

Tax

Adjustments

Non-

GAAP

Measure

Net income (loss)

$ (64,907)

$ 80,324

$ 13,369

$ 2,150

$ (591)

$ 30,345

Shares Excluded Due to Net Loss

Diluted shares outstanding

32,721

260

32,981

Diluted earnings (loss) per share

$ (1.98)

$ 0.92

* Represents pre-tax amounts

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

January 3,

2026

December 28,

2024

Assets

Current assets:

Cash and cash equivalents

$ 364,222

$ 281,607

Short-term investments

79,400

100,554

Accounts receivable, net

64,513

54,479

Inventories

95,566

105,639

Prepaid expenses and other current assets

70,316

59,754

Total current assets

674,017

602,033

Property and equipment, net

128,643

132,136

Goodwill

376,389

Other intangible assets, net

23,130

36,499

Other assets, net

67,138

75,617

Total assets

$ 1,269,317

$ 1,222,674

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable

$ 50,717

$ 42,448

Deferred revenue and returns liability

5,359

3,073

Other current liabilities

87,711

52,362

Total current liabilities

143,787

97,883

Other non-current liabilities

31,112

44,770

Total liabilities

174,899

142,653

Commitments and contingencies

Stockholders' equity:

Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued

—

Common stock – $0.0001 par value; 250,000 shares authorized; 32,955 and 32,458

shares issued and outstanding at January 3, 2026 and December 28, 2024,

respectively

Additional paid-in capital

157,402

78,227

Retained earnings

936,814

1,001,721

Accumulated other comprehensive income

199

Total stockholders' equity

1,094,418

1,080,021

Total liabilities and stockholders' equity

$ 1,269,317

$ 1,222,674

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Year Ended

January 3,

2026

December 28,

2024

Operating Activities

Net loss

$ (64,907)

$ (191,010)

Adjustments to reconcile net loss to net cash provided by (used in) operating

activities:

Depreciation of property and equipment

24,716

25,551

Amortization of other intangible assets

13,369

23,034

Stock-based compensation expense

80,324

61,503

Deferred income taxes

881

29,470

Changes in operating assets and liabilities:

Accounts receivable

(10,034)

(25,184)

Inventories

9,992

88,494

Prepaid expenses and other assets

8,826

27,362

Accounts payable

6,333

(15,155)

Other current liabilities and income taxes

36,781

(21,768)

Deferred revenue and returns liability

2,286

956

Other non-current liabilities

(12,859)

(17,163)

Net cash provided by (used in) operating activities

95,708

(13,910)

Investing Activities

Purchases of marketable securities

(34,790)

(73,602)

Sales of marketable securities

15,393

54,227

Maturities of marketable securities

40,716

131,858

Purchases of property and equipment

(29,922)

(11,748)

Proceeds from capital-related government incentives

578

—

Proceeds from sale of equity investment

—

12,382

Purchases of other assets

(4,000)

—

Net cash provided by (used in) investing activities

(12,025)

113,117

Financing Activities

Payments on debt

—

(45,000)

Repurchases of common stock

—

(16)

Payment of taxes withheld for vested stock awards

(15,706)

(16,434)

Proceeds from the issuance of common stock

14,638

16,346

Net cash used in financing activities

(1,068)

(45,104)

Increase in cash and cash equivalents

82,615

54,103

Cash and cash equivalents at beginning of period

281,607

227,504

Cash and cash equivalents at end of period

$ 364,222

$ 281,607

SOURCE Silicon Labs